Philochem AG
Records under this name other than the patents Philochem AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,263,041 | Novel Antigen Associated with the Neovasculature of Tumour Metastases Formerly held In force · High confidence | In force | High confidence | |
| US 10,202,442 | Antigen Associated with Lung Cancers and Lymphomas Formerly held In force · High confidence | In force | High confidence | |
| US 9,181,347 | Novel Antigen Associated with the Neovasculature of Tumour Metastases Formerly held In force · High confidence | In force | High confidence | |
| US 8,222,377 | Antigen associated with rheumatoid arthritis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,385,121 | Antigen associated with rheumatoid arthritis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,556,257 | Antigen associated with rheumatoid arthritis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,695,232 | Anti-Ed-A Immunoconjugates for Inflammatory Bowel Disease Formerly held In force · High confidence | In force | High confidence | |
| US 10,016,511 | Small Molecule Drug Conjugates Formerly held In force · High confidence | In force | High confidence | |
| US 11,103,592 | IL2 and TNF mutant immunoconjugates Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,173,044 | EDB Targeting IL-12 Compositions Formerly held In force · High confidence | In force | High confidence |